Funding
Who raised, when, and from whom? Explore announced rounds, including emerging Indian companies, and company-reported SEC notices. Each amount keeps its original source and date.
363 filings · Form D notices of private raises, 2024-01-02 to 2026-03-31
BiomX Inc.Pharmaceuticals
Ness Ziona, Israel · Equity, Options, Convertible · 1 investors · Jesse Goodman, Alan Moses
Alveus Therapeutics, Inc.Pharmaceuticals
Philadelphia, Pennsylvania · founded 2023 · Equity · 17 investors · Claudio Nessi, Ameet Nathwani
ABLi Therapeutics, Inc.Pharmaceuticals
Atlanta, Georgia · founded 2025 · Equity · 10 investors · Jeffrey Young, Milton Werner
Vogenx, Inc.Pharmaceuticals
Raleigh, North Carolina · founded 2021 · Debt · 3 investors · William Wilkison, Pete Pieraccini
Matthias Therapeutics, LLCPharmaceuticals
Basking Ridge, New Jersey · founded 2023 · Debt, Options · 2 investors · Matthew Redling
Nacuity Pharmaceuticals, Inc.Pharmaceuticals
Fort Worth, Texas · Equity, Debt, Options, Convertible, Convertible Promissory Notes convertible int · 98 investors · Michael Wall, Robin Steele
Cytogel Pharma, LLCPharmaceuticals
Darien, Connecticut · Debt, Options · 3 investors · Michael Ullmann, Frederick Telling
Aeovian Pharmaceuticals, Inc.Pharmaceuticals
Berkeley, California · Equity · 13 investors · John Kincaid, Youssef Bennani
Avana Health, Inc.Pharmaceuticals
Lexington, Kentucky · founded 2021 · Equity, Options, conversion of SAFE's · 29 investors · Peter Pacult, Howard Settle
Paulex Bio Inc.Pharmaceuticals
La Jolla, California · founded 2023 · Equity, Options · 163 investors · Edgardo Rayo, Mohammad Hayat
NextEvo, Inc.Pharmaceuticals
Conshohocken, Pennsylvania · Equity · 1 investors · Cornelius Merlini, Gerald Stahlecker
Revalesio CorpPharmaceuticals
Tacoma, Washington · Equity, Debt, Options, Convertible · 31 investors · James Nordstrom, Eric Russell
Revalesio CorpPharmaceuticals
Tacoma, Washington · Equity, Debt, Options, Convertible · 31 investors · James Nordstrom, Eric Russell
FibroBiologics, Inc.Pharmaceuticals
Houston, Texas · founded 2021 · Equity, Options, Convertible · 4 investors · Robert Hoffman, Matthew Link
LivFul Inc.Pharmaceuticals
Temple, Texas · Equity · 2 investors · Hogan Bassey, Matt Elsberry
BlossomHill Therapeutics, Inc.Pharmaceuticals
San Diego, California · Equity · 47 investors · George Lee, Carl Gordon
Verrica Pharmaceuticals Inc.Pharmaceuticals
West Chester, Pennsylvania · Equity, Options, Convertible · 21 investors · Mark Prygocki, Noah Rosenberg
Apnimed, Inc.Pharmaceuticals
Cambridge, Massachusetts · Debt, Convertible · 7 investors · Kevin Lind, Ramzi Benamar
Triana Biomedicines, Inc.Pharmaceuticals
Lexington, Massachusetts · Equity · 20 investors · Patrick Trojer, Joshua Resnick
ADIAL PHARMACEUTICALS, INC.Pharmaceuticals
Glen Allen, Virginia · Options, Convertible · 1 investors · James Newman, Jr., James Anderson
FibroBiologics, Inc.Pharmaceuticals
Houston, Texas · founded 2021 · Equity, Options, Convertible · 1 investors · Pete O'Heeron, Jason Davis
Pneuma Respiratory, Inc.Pharmaceuticals
Boone, North Carolina · Debt, Convertible Notes · 14 investors · J. Singleton, Douglas Stoner
Pneuma Respiratory, Inc.Pharmaceuticals
Boone, North Carolina · Debt, Convertible Notes · 26 investors · Jay Morgan, Douglas Stoner
FibroBiologics, Inc.Pharmaceuticals
Houston, Texas · founded 2021 · Equity, Options, Convertible · 4 investors · Stacy Coen, Matthew Link
BTB Therapeutics, Inc.Pharmaceuticals
Escondido, California · founded 2024 · Equity · 4 investors · Masatoshi Hagiwara, Nobuhiro Yagi
Par Health, Inc.Pharmaceuticals
St. Louis, Missouri · founded 2025 · Equity · 234 investors · Teresa Sanzottera, Jake Longenecker
Pelage Pharmaceuticals, Inc.Pharmaceuticals
Los Angeles, California · Equity · 5 investors · Cathy Friedman, Nathan Wheeler
Kamal Therapeutics, Inc.Pharmaceuticals
Hingham, Massachusetts · founded 2020 · Equity · 41 investors · Mark de Souza, Philip Reilly
Jaguar Health, Inc.Pharmaceuticals
San Francisco, California · Debt · Carol Lizak, John Micek III
XTRESSE, LLCPharmaceuticals
Orlando, Florida · founded 2025 · Equity · 30 investors · Matt Leavitt